JavaScript is disabled for your browser. Some features of this site may not work without it.
Dynorphin immunocytochemistry in the rat central nervous system
Khachaturian, Henry; Watson, Stanley J.; Lewis, Michael E.; Coy, David H.; Goldstein, Avram; Akil, Huda
1982
Citation:Khachaturian, Henry, Watson, Stanley J., Lewis, Michael E., Coy, David, Goldstein, Avram, Akil, Huda (1982)."Dynorphin immunocytochemistry in the rat central nervous system." Peptides 3(6): 941-954. <http://hdl.handle.net/2027.42/23823>
Abstract: The distribution of dynorphin in the central nervous system was investigated in rats pretreated with relatively high doses (300-400 [mu]g) of colchicine administered intracerebroventricularly. To circumvent the problems of antibody cross-reactivity, antisera were generated against different portions as well as the full dynorphin molecule (i.e., residues 1-13, 7-17, or 1-17). For comparison, antisera to [Leu]enkephalin (residues 1-5) were also utilized. Dynorphin was found to be widely distributed throughout the neuraxis. Immunoreactive neuronal perikarya exist in hypothalamic magnocellular nuclei, periaqueductal gray, scattered reticular formation sites, and other brain stem nuclei, as well as in spinal cord. Additionally, dynorphin-positive fibers or terminals occur in the cerebral cortex, olfactory bulb, nucleus accumbens, caudate-putamen, globus pallidus, hypothalamus, substantia nigra, periaqueductal gray, many brain stem sties, and the spinal cord. In many areas studied, dynorphin and enkephalin appeared to form parallel but probably separate anatomical systems. The results suggest that dynorphin occurs in neuronal systems that are immunocytochemically distinct from those containing other opioid peptides.